Filter results
You can narrow down the results using the filters
Audience
Topics
Our work
Year
2 results
-
$400 million to help researchers pursue big ideas, develop new health and medical breakthroughs and apply them to clinical practice
Researchers can apply for funding under the 2022 Frontier Health and Medical Research grant opportunity from 13 February 2023. Funding is from the Medical Research Future Fund (MRFF). -
Soliris® (eculizumab) available on PBS from 1 March 2022
The program that subsidises Soliris® for patients with a rare condition called paroxysmal nocturnal haemoglobinuria (PNH) is changing. Until now, we have subsidised Soliris® under the Life Saving Drugs Program. From 1 March 2022, this will change to the Pharmaceutical Benefits Scheme (PBS).